urban-gro (UGRO) We Have Another Double!
Last May we asked, "Is Urban-Gro the Most Undervalued Cannabis Play in the Market?" Looks like it was, having doubled less than...
urban-gro (UGRO) $10.15 Marijuana’s First Fully Integrated Indoor Cultivation Powerhouse.
urban-gro announces its first major acquisition since raising $62 million in February and it's a doozey! The inclusion of architecture allows them...
Is urban-gro (UGRO) $7.50, the Most Undervalued Cannabis Play in the Market?
Listen to Today's Conference Call at 5:00 PM EST to Find Out for Yourself.
What the, look at...
Urban Gro (UGRO) $8.00 Conference Call 8:30 This Morning.
urban-gro, Inc. to Report Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call
– Company to...
Wall Street Pounces on Hydroponics.
Indoor Growing & Hydroponics Outperform Both the Market and Marijuana Sector.
Investor attention is...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
